T315L: a novel mutation within BCR-ABL kinase domain confers resistance against ponatinib

The patients of philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) have been shown to have particularly poor prognosis.[1] The combined treatment of BCR-ABL specific tyrosine kinase inhi...